Medical marijuana in neurology

@article{Benbadis2014MedicalMI,
  title={Medical marijuana in neurology},
  author={Selim R Benbadis and Juan R. Sanchez-Ramos and Ali M. Bozorg and Melissa Giarratano and Kavita Kalidas and Lara W Katzin and Derrick Robertson and Tuan Vu and Amanda Smith and Theresa Zesiewicz},
  journal={Expert Review of Neurotherapeutics},
  year={2014},
  volume={14},
  pages={1453 - 1465}
}
Constituents of the Cannabis plant, cannabinoids, may be of therapeutic value in neurologic diseases. The most abundant cannabinoids are Δ9-tetrahydrocannabinol, which possesses psychoactive properties, and cannabidiol, which has no intrinsic psychoactive effects, but exhibits neuroprotective properties in preclinical studies. A small number of high-quality clinical trials support the safety and efficacy of cannabinoids for treatment of spasticity of multiple sclerosis, pain refractory to… 
Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?
  • E. Perucca
  • Medicine, Psychology
    Journal of epilepsy research
  • 2017
TLDR
There is now class 1 evidence that adjunctive use of CBD improves seizure control in patients with specific epilepsy syndromes, for the first time, according to currently available information.
Cannabis and Endocannabinoid Signaling in Epilepsy.
  • I. Katona
  • Medicine, Biology
    Handbook of experimental pharmacology
  • 2015
TLDR
Current preclinical and clinical efforts for cannabinoid- or endocannabinoid-based epilepsy treatments are introduced and recent advances in knowledge of how endoc cannabinoidoid signaling limits abnormal network activity as a central component of the synaptic circuit-breaker system are reviewed.
Cannabinoids for the Treatment of Movement Disorders
TLDR
There is growing evidence of a “cannabinoid entourage effect” in which a combination of cannabinoids derived from the plant are more effective than any single cannabinoid for a number of conditions.
Is cannabidiol the ideal drug to treat non-motor Parkinson’s disease symptoms?
TLDR
CBD was well tolerated, and all three studies reported significant therapeutic effects in non-motor symptoms of PD, however, sample sizes were small and CBD treatment was short, so large-scale RCTs are needed to try to replicate these results and to assess the long-term safety of CBD.
Cannabis in the Treatment of Dystonia, Dyskinesias, and Tics
TLDR
Clinical research is reviewed using various formulations of cannabis (botanical products, oral preparations containing ∆9-tetrahydrocannabinol and/or cannabidiol) and currently available preparations in the USA (nabilone and dronabinol), expanded from a recent systematic review to include case reports and case series and results of anonymous surveys of patients using cannabis outside of medical settings.
Cannabis therapy in neurological disorders: Recent advances and perspectives
TLDR
Although there are clinical studies supporting the use of cannabis preparations as adjuvant therapy in neurological disorders, more investigations are needed to assess their safety and efficacy.
Cannabinoids in Neurologic Conditions
TLDR
The aim of this chapter is to provide practical, MS-relevant information about the benefits and risks of cannabis so that health professionals may effectively provide objective cannabis information, facilitate informed decision-making, and optimize safety and effectiveness in those patients who choose to use cannabis.
Reply to Letter
  • C. Saper
  • Medicine
    Annals of neurology
  • 2015
TLDR
The federal government should reschedule cannabis and allow scientists to develop a rational approach to cannabinoid therapeutics that takes into account the entourage effect, a recent review of the phytocannabinoids suggests.
The current state and potential direction of cannabis research
TLDR
The underlying conditions that are significantly controlled or modulated by cannabis are discussed to provide the medical community with a broad synopsis of recent research trials on Cannabis sativa that have indicated its medicinal benefits.
Therapeutic applications of cannabinoids.
...
1
2
3
4
...

References

SHOWING 1-10 OF 116 REFERENCES
Safety and side effects of cannabidiol, a Cannabis sativa constituent.
TLDR
In vivo and in vitro reports of CBD administration across a wide range of concentrations suggest controlled CBD may be safe in humans and animals, but further studies are needed to clarify reported in vitro and in vivo side effects.
Cannabinoids and Hallucinogens for Headache
TLDR
Hallucinogens and most cannabinoids are classified under schedule 1 of the Federal Controlled Substances Act 1970, along with heroin and ecstacy, and are still used by patients as a migraine abortive in particular.
Cannabinoids: novel medicines for the treatment of Huntington's disease.
TLDR
The present review will address all preclinical evidence supporting the potential of Sativex® for the treatment of disease progression in HD patients and presents some promising patents on the cannabinoids.
The Pharmacologic and Clinical Effects of Medical Cannabis
TLDR
The pharmacology of cannabis, effects of various dosage formulations, therapeutics benefits and risks of cannabis for pain and muscle spasm, and safety concerns of medical cannabis use are described.
Cannabinoids as pharmacotherapies for neuropathic pain: From the bench to the bedside
Medical marijuana and the developing role of the pharmacist.
PURPOSE The pharmacology, therapeutic uses, safety, drug-drug interactions, and drug-disease interactions of medical marijuana are reviewed, and the legal issues related to its use and the
Cluster Attacks Responsive to Recreational Cannabis and Dronabinol
TLDR
A patient with cluster headache who was refractory to multiple acute and preventive medications but successfully aborted his attacks with recreational marijuana use is presented and subsequent use of dronabinol provided equally effective pain relief.
Controlled clinical trial of cannabidiol in Huntington's disease
Cannabinoids in medicine: A review of their therapeutic potential.
TLDR
Cannabinoids present an interesting therapeutic potential as antiemetics, appetite stimulants in debilitating diseases, analgesics, and in the treatment of multiple sclerosis, spinal cord injuries, Tourette's syndrome, epilepsy and glaucoma.
Neuroprotective Antioxidants from Marijuana a
TLDR
Preliminary studies in a rat model of focal cerebral ischemia suggest that cannabidiol may be at least as effective in vivo as seen in these in vitro studies, and cannabinoids can act as an antioxidants in neuronal cultures.
...
1
2
3
4
5
...